US Markets

U.S. judge overseeing opioid litigation won't be disqualified -U.S. appeals court

Credit: REUTERS/George Frey

A federal appeals court on Thursday rejected a bid by eight drug retailers and distributors to disqualify the judge overseeing nationwide opioid litigation, after they claimed his rulings, public statements and efforts to encourage settlements created an appearance of bias.

Oct 10 (Reuters) - A federal appeals court on Thursday rejected a bid by eight drug retailers and distributors to disqualify the judge overseeing nationwide opioid litigation, after they claimed his rulings, public statements and efforts to encourage settlements created an appearance of bias.

The ruling, by the 6th U.S. Circuit Court of Appeals in Cincinnati, means U.S. District Judge Dan Polster can continue presiding over the litigation, including a landmark trial scheduled to begin in Cleveland on Oct. 21.

Companies that sought Polster's removal included retailers CVS Health Corp CVS.N, Rite Aid Corp RAD.N, Walgreens Boots Alliance Inc WBA.O and Walmart Inc WMT.N, and distributors AmerisourceBergen Corp ABC.N, Cardinal Health Inc CAH.N, Henry Schein Inc HSIC.O and McKesson Corp MCK.N.

(Reporting by Jonathan Stempel in New York)

((jon.stempel@thomsonreuters.com; +1 646 223 6317; Reuters Messaging: jon.stempel.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest US Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More